CRISPR-Cas9 in Cardiovascular Medicine: Unlocking New Potential for Treatment

CRISPR-Cas9 in Cardiovascular Medicine: Unlocking New Potential for Treatment

Cardiovascular diseases (CVDs) remain a significant global health challenge, with many current treatments addressing symptoms rather than the genetic roots of these conditions. The advent of CRISPR-Cas9 technology has revolutionized genome editing, offering a transformative approach to targeting dis...

Full description

Saved in:
Bibliographic Details
Main Authors: Klaudia Bonowicz, Dominika Jerka, Klaudia Piekarska, Janet Olagbaju, Laura Stapleton, Munirat Shobowale, Andrzej Bartosiński, Magdalena Łapot, Yidong Bai, Maciej Gagat
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Cells
Subjects:
cardiovascular diseases (CVDs)
CRISPR-Cas9
gene therapy
mitochondrial genome editing
Online Access:https://www.mdpi.com/2073-4409/14/2/131
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items